Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-09-27

FDA Approved: ALPRAZOLAM — Supplemental Application (Par Health USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for alprazolam (generic) under Par Health USA, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alprazolam (alprazolam)

Snippet

SUPPL AP for ALPRAZOLAM (ALPRAZOLAM)